Literature DB >> 10980955

Cystic fibrosis colonopathy.

J D Lloyd-Still1, D W Beno, R M Kimura.   

Abstract

An epidemic of fibrosing colonopathy, a new disease caused by the prolonged administration of excessive doses of pancreatic enzymes, was first reported in 1994. More than 60 cases were known to occur worldwide before dosage guidelines were enforced. Predisposing factors were young age, previous intestinal surgery, meconium ileus equivalent, and use of H2 blockers, corticosteroids, and DNase. Abnormal features included foreshortened colon, strictures, marked submucosal fibrosis, ascites, and nodular hyperplasia of the liver. Histologic examination showed eosinophilia, mild cryptitis, epithelial regeneration, and widespread interruption of the muscularis mucosa. These findings are distinct from, but share many of the features of, those of Crohn's's disease and ischemic bowel disease. The pathogenic mechanisms remain unknown.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10980955     DOI: 10.1007/s11894-999-0040-4

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  28 in total

1.  Fibrosing colonopathy in children with cystic fibrosis.

Authors:  K W Reichard; C D Vinocur; M Franco; K L Crisci; J A Flick; D F Billmire; D V Schidlow; W H Weintraub
Journal:  J Pediatr Surg       Date:  1997-02       Impact factor: 2.545

2.  The effect of intestinal permeability on pancreatic enzyme-induced enteropathy in the rat.

Authors:  J D Lloyd-Still; M R Uhing; V Arango; A Fusaro; R E Kimura
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-05       Impact factor: 2.839

3.  Extensive pathological changes of the colon in cystic fibrosis and high-strength pancreatic enzymes.

Authors:  N Knabe; M Zak; A Hansen; J Moesgaard; N Kvist; B Beck; K Damgaard; C Koch
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

4.  High strength pancreatic exocrine enzyme capsules associated with colonic strictures in patients with cystic fibrosis: "more is not necessarily better".

Authors:  E Lebenthal
Journal:  J Pediatr Gastroenterol Nutr       Date:  1994-05       Impact factor: 2.839

5.  High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.

Authors:  S C FitzSimmons; G A Burkhart; D Borowitz; R J Grand; T Hammerstrom; P R Durie; J D Lloyd-Still; A B Lowenfels
Journal:  N Engl J Med       Date:  1997-05-01       Impact factor: 91.245

6.  Colonic strictures in children with cystic fibrosis.

Authors:  J M Zerin; J Kuhn-Fulton; S J White; S K Chong; J C Stevens; K W West; D H Teitelbaum; S Z Nasr
Journal:  Radiology       Date:  1995-01       Impact factor: 11.105

7.  Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.

Authors:  P R Durie; L Bell; W Linton; M L Corey; G G Forstner
Journal:  Gut       Date:  1980-09       Impact factor: 23.059

Review 8.  Crohn's disease and cystic fibrosis.

Authors:  J D Lloyd-Still
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

9.  Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.

Authors:  R L Smyth; D van Velzen; A R Smyth; D A Lloyd; D P Heaf
Journal:  Lancet       Date:  1994-01-08       Impact factor: 79.321

10.  Cystic fibrosis-associated colitis and fibrosing colonopathy.

Authors:  S J Schwarzenberg; C L Wielinski; I Shamieh; B L Carpenter; J Jessurun; S A Weisdorf; W J Warwick; H L Sharp
Journal:  J Pediatr       Date:  1995-10       Impact factor: 4.406

View more
  5 in total

Review 1.  Wound healing and fibrosis in intestinal disease.

Authors:  F Rieder; J Brenmoehl; S Leeb; J Schölmerich; G Rogler
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

2.  Treatment of Gastrointestinal Problems in Cystic Fibrosis.

Authors:  Maria R. Mascarenhas
Journal:  Curr Treat Options Gastroenterol       Date:  2003-10

3.  Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency.

Authors:  Kei Nakajima; Haruki Oshida; Toshitaka Muneyuki; Masafumi Kakei
Journal:  Core Evid       Date:  2012-07-19

4.  Successful non-invasive treatment of stricturing fibrosing colonopathy in an adult patient.

Authors:  G Terheggen; D Dieninghoff; E Rietschel; U Drebber; W Kruis; L Leifeld
Journal:  Eur J Med Res       Date:  2011-09-12       Impact factor: 2.175

5.  Evidence for a Cystic Fibrosis Enteropathy.

Authors:  Marlou P M Adriaanse; Linda J T M van der Sande; Anita M van den Neucker; Paul P C A Menheere; Edward Dompeling; Wim A Buurman; Anita C E Vreugdenhil
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.